Evidence map›Paper›PMID 11854193›Full record

ArticleInfection and immunity2002

Identification and characterization of a nonimmunoglobulin factor in human saliva that inhibits Streptococcus mutans glucosyltransferase.

Christina Jespersgaard, George Hajishengallis, Michael W Russell, Suzanne M Michalek

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Oral streptococci: modulators of health and disease.Frontiers in cellular and infection microbiology · 2024
    Review
  4. Review
  5. Murine Salivary Amylase Protects AgainstFrontiers in physiology · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christina JespersgaardDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
George Hajishengallis
Michael W Russell
Suzanne M Michalek
University of Alabama at Birmingham · US

Funding

Genetically Engineered Oral Vaccines &Caries ImmunityR01DE009081 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MICHALEK, SUZANNE M. · 1990 to 2012
$3.2M
ANTIGENS OF STREPTOCOCCUS MUTANS IN CARIES IMMUNITYR37DE006746 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RUSSELL, MICHAEL W · 1999 to 2008
$2.4M
REGULATION OF IMMUNE RESPONSES IN THE ORAL CAVITYR01DE008182 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MICHALEK, SUZANNE M. · 1988 to 2003
$972k
PROTEIN ANTIGENS OF STREP MUTANS IN CARIES IMMUNITYR01DE006746 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RUSSELL, MICHAEL W · 1985 to 1998
–
NIDCR NIH HHS DE06746NIDCR NIH HHS DE08182NIDCR NIH HHS DE09801NIDCR NIH HHS R01 DE008182NIDCR NIH HHS R01 DE009081NIDCR NIH HHS R37 DE006746
6 · The paper itself

Abstract

Saliva contains an array of nonimmunoglobulin defense factors which are thought to contribute to the protection of the hard and soft tissue surfaces of the oral cavity by modulating microbial colonization and metabolism. Here we report the discovery of a putative innate defense factor in human saliva that inhibits the glucosyltransferase (GTF) of Streptococcus mutans, a virulence enzyme involved in oral colonization by this pathogen. The GTF-inhibiting factor (GIF) was initially identified as a nonimmunoglobulin salivary component that interfered with detection of antibodies to the glucan-binding region (GLU) of GTF by an enzyme-linked immunosorbent assay. This inhibitory activity was present in whole saliva and submandibular-sublingual saliva, but it was essentially absent from parotid saliva. GIF inhibited the recognition of S. mutans cell surface-associated GTF by specific antibodies but had no effect on antibodies to other cell surface antigens, suggesting that GIF specifically binds to GTF on S. mutans. GIF purified by size exclusion or affinity chromatography was used for biochemical and functional characterization. Analysis of GIF by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a high-molecular-weight glycoprotein after staining with Coomassie blue or Schiff's reagent. Heating and reduction with 2-mercaptoethanol of GIF resulted in the release of a approximately 58-kDa protein that was identified as alpha-amylase by Western blotting using anti-alpha-amylase antibodies. GLU bound blotted alpha-amylase, suggesting that the latter molecule is the GLU-binding component of the GIF complex. The ability of GTF to synthesize extracellular glucans was inhibited by GIF but not by uncomplexed alpha-amylase or an unrelated high-molecular-weight glycoprotein. In conclusion, our findings demonstrate that in human saliva, there is a high-molecular-weight glycoprotein-alpha-amylase complex which is capable of inhibiting GTF and may contribute to control of S. mutans colonization in the oral cavity.

Indexed as

GlucosyltransferasesGlycoproteinsHumansProtein BindingSalivaSalivary Proteins and PeptidesStreptococcus mutansGlucosyltransferasesGlycoproteinsSalivary Proteins and Peptides

Identifiers

PMID11854193
PMCPMC127793
OpenAlexW2146401665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.